CS logo
small CS logo
Faculdade de Ciências Médicas - UNICAMP

Campinas, Sao Paulo, Brazil
College in Campinas, State of São Paulo
R. Tessália Vieira de Camargo, 126 - Cidade Universitária, Campinas - SP, 13083-887

About Faculdade de Ciências Médicas - UNICAMP


The School of Medical Sciences is a college of the State University of Campinas, located in Campinas, São Paulo, Brazil. It offers courses at the undergraduate level in medicine, nursing, pharmacy and speech therapy, as well as courses at graduate and postgraduate level.
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Boehringer Ingelheim
3
Eli Lilly and Company
3
PTC Therapeutics
2
Pfizer
2
Total Rows: 4

Clinical Trials at Faculdade de Ciências Médicas - UNICAMP


During the past decade, Faculdade de Ciências Médicas - UNICAMP conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 6 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 5 clinical trials were completed. i.e. 250% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years11000022111100110000001100331111Started TrialsCompleted Trails2015201620172018201920202021202201234
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Open Label Study Comparing Efficacy and Safety of Dabigatran Etexilate to Standard of Care in Paediatric Patients With Venous Thromboembolism (VTE)
2013-09-25
2019-11-14
Completed
267
Safety and Efficacy Study of Enzalutamide in Patients With Nonmetastatic Castration-Resistant Prostate Cancer
2013-10-31
2023-12-29
Active, not recruiting
1,401
Safety of Dabigatran Etexilate in Blood Clot Prevention in Children
2014-09-29
2019-11-19
Completed
214
Safety and Efficacy Study of Enzalutamide Plus Leuprolide in Patients With Nonmetastatic Prostate Cancer (EMBARK)
2014-12-17
2026-09-19
Active, not recruiting
1,068
RE-COVERY DVT/PE: Global Study on Treatment Secondary Prevention of Acute Venous Thromboembolism
2015-11-05
2019-03-31
Completed
7,797
A Long-term Study of Baricitinib (LY3009104) With Topical Corticosteroids in Adults With Moderate to Severe Atopic Dermatitis That Are Not Controlled With Cyclosporine or for Those Who Cannot Take Oral Cyclosporine Because it is Not Medically Advisable
2018-05-15
2023-05-02
Active, not recruiting
463
A Study of Baricitinib in Participants From 2 Years to Less Than 18 Years Old With Juvenile Idiopathic Arthritis
2018-12-17
2022-01-26
Completed
220
A Study of Baricitinib (LY3009104) in Adults With Severe or Very Severe Alopecia Areata
2019-07-08
2024-05-27
Active, not recruiting
546

Rows per page:

1–10 of 10

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "Faculdade de Ciências Médicas - UNICAMP" #1 collaborator was "Astellas Pharma Inc" with 2 trials as a collaborator, "Incyte Corporation" with 2 trials as a collaborator and "Medivation LLC, a wholly owned subsidiary of Pfizer Inc." with 2 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.
Created with Highcharts 11.1.0Top Leading SponsorsBoehringer Ingelheim: 3Boehringer Ingelheim: 3Eli Lilly and Company: 3Eli Lilly and Company: 3PTC Therapeutics: 2PTC Therapeutics: 2Pfizer: 2Pfizer: 2

Created with Highcharts 11.1.0Top CollaboratorsAstellas Pharma Inc: 2Astellas Pharma Inc: 2Incyte Corporation: 2Incyte Corporation: 2Medivation LLC, awholly ownedsubsidiary of Pfizer Inc.:2Medivation LLC, awholly ownedsubsidiary of Pfizer Inc.:2

Clinical Trials Conditions at Faculdade de Ciências Médicas - UNICAMP


According to Clinical.Site data, the most researched conditions in "Faculdade de Ciências Médicas - UNICAMP" are "Venous Thromboembolism" (3 trials), "Cancer of the Prostate" (2 trials), "Friedreich Ataxia" (2 trials), "Prostate Cancer" (2 trials) and "Alopecia Areata" (1 trials). Many other conditions were trialed in "Faculdade de Ciências Médicas - UNICAMP" in a lesser frequency.

Clinical Trials Intervention Types at Faculdade de Ciências Médicas - UNICAMP


Most popular intervention types in "Faculdade de Ciências Médicas - UNICAMP" are "Drug" (9 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (6 trials), "Baricitinib" (3 trials), "Enzalutamide" (2 trials), "Vatiquinone" (2 trials) and "dabigatran etexilate" (2 trials). Other intervention names were less common.

Clinical Trials Genders at Faculdade de Ciências Médicas - UNICAMP


The vast majority of trials in "Faculdade de Ciências Médicas - UNICAMP" are 8 trials for "All" genders and 2 trials for "Male" genders.

Clinical Trials Status at Faculdade de Ciências Médicas - UNICAMP


Currently, there are NaN active trials in "Faculdade de Ciências Médicas - UNICAMP". undefined are not yet recruiting, undefined are recruiting, 5 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 4 completed trials in Faculdade de Ciências Médicas - UNICAMP, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Faculdade de Ciências Médicas - UNICAMP, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 9Phase 3: 9Phase 2: 1Phase 2: 1

Created with Highcharts 11.1.0Trials StatusActive, not recruiting: 5Active, not recruiting: 5Completed: 4Completed: 4Enrolling by invitation: 1Enrolling by invitation: 1